loading
Orchestra Biomed Holdings Inc stock is traded at $3.22, with a volume of 81,832. It is up +0.94% in the last 24 hours and up +0.00% over the past month. Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$3.19
Open:
$3.2
24h Volume:
81,832
Relative Volume:
0.17
Market Cap:
$123.37M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-2.1467
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
+1.58%
1M Performance:
+0.00%
6M Performance:
-39.59%
1Y Performance:
-59.75%
1-Day Range:
Value
$3.05
$3.30
1-Week Range:
Value
$3.0401
$3.30
52-Week Range:
Value
$2.37
$8.30

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name
Name
Orchestra Biomed Holdings Inc
Name
Phone
646-343-9298
Name
Address
150 UNION SQUARE DRIVE, NEW HOPE
Name
Employee
70
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
OBIO's Discussions on Twitter

Compare OBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OBIO
Orchestra Biomed Holdings Inc
3.22 122.60M 2.76M -49.12M -46.21M -1.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-20-25 Initiated BTIG Research Buy
Jan-02-25 Initiated Barclays Overweight
Aug-22-24 Initiated H.C. Wainwright Buy
Jul-25-24 Initiated B. Riley Securities Buy
Jan-19-24 Initiated Jefferies Buy
Feb-24-23 Initiated Piper Sandler Overweight
Feb-07-23 Initiated Chardan Capital Markets Buy
View All

Orchestra Biomed Holdings Inc Stock (OBIO) Latest News

pulisher
05:17 AM

IFP Advisors Inc Acquires 83,481 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

05:17 AM
pulisher
Jul 23, 2025

Is Orchestra BioMed Holdings Inc. a good long term investmentPowerful growth strategies - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Orchestra BioMed Holdings Inc. stock priceFree Advanced Stock Screener Access - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Orchestra BioMed Holdings Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Orchestra BioMed Holdings Inc. stockRapid market gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionFree Predictions - Newser

Jul 22, 2025
pulisher
Jul 15, 2025

How Orchestra BioMed Holdings Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Orchestra BioMed Holdings Inc. stock price move sharplyMinimized Risk Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

How To Trade (OBIO) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 12, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Buy” by Brokerages - Defense World

Jul 12, 2025
pulisher
Jul 10, 2025

Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% – Here’s What Happened - Defense World

Jul 10, 2025
pulisher
Jul 05, 2025

Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MSN

Jul 05, 2025
pulisher
Jul 05, 2025

Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MSN

Jul 05, 2025
pulisher
Jul 02, 2025

Hedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year losses - simplywall.st

Jul 02, 2025
pulisher
Jul 02, 2025

Learn to Evaluate (OBIO) using the Charts - news.stocktradersdaily.com

Jul 02, 2025
pulisher
Jul 02, 2025

Orchestra BioMed: A Contrarian Gem in the Biotech Doldrums - AInvest

Jul 02, 2025
pulisher
Jun 29, 2025

Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) dropped from Russell Small Cap Comp Value Index - MarketScreener

Jun 29, 2025
pulisher
Jun 24, 2025

Orchestra BioMed Confirms Director Elections and Auditor - TipRanks

Jun 24, 2025
pulisher
Jun 18, 2025

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire

Jun 18, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

(OBIO) Trading Advice - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 02, 2025

Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks

Jun 02, 2025
pulisher
May 30, 2025

B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World

May 30, 2025
pulisher
May 28, 2025

Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha

May 28, 2025
pulisher
May 21, 2025

Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN

May 21, 2025
pulisher
May 19, 2025

The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 19, 2025
pulisher
May 18, 2025

FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World

May 18, 2025

Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Cap:     |  Volume (24h):